Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
about
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitorsTargeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)The Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck CancerBiomarkers of head and neck cancer, tools or a gordian knot?Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerCurrent role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinomaNanoparticle-based targeted therapeutics in head-and-neck cancerRole of chemotherapy in nasopharyngeal carcinomaHER2 as a therapeutic target in head and neck squamous cell carcinomaSafety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck CancerToward the use of precision medicine for the treatment of head and neck squamous cell carcinomaCellular functions of TMEM16/anoctaminGenome stability pathways in head and neck cancersSusceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolismThe Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiationHonokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosisEpidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinomaUltrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer.Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment responseMMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.The impact of sphingosine kinase-1 in head and neck cancer.Integration of biomarkers including molecular targeted therapies in head and neck cancer.Clinical update on cancer: molecular oncology of head and neck cancerSelective uptake and imaging of aptamer- and antibody-conjugated hollow nanospheres targeted to epidermal growth factor receptors overexpressed in head and neck cancerAdvances in the management of squamous cell carcinoma of the head and neck.Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer.Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinomaTargeting the epidermal growth factor receptor for head and neck cancer chemopreventionThe phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer
P2860
Q24812583-DD4485C1-6A67-49C8-8CB7-C667DA029140Q26745755-7D3D0EE2-B0E1-41B0-A887-5A5B8459F3DAQ26750719-AE0BB0E2-402B-480F-9FAB-D3673F78C1D0Q26765429-68A82A32-2E92-4DE4-B815-3C28EAE9794FQ26778433-088B2ADF-B33F-4F77-966E-23E7183524F8Q26784289-A76756BA-82A3-47D3-9E40-EA2F62732F8CQ26852215-229D5A85-BE15-415E-9518-A1CAADE24C8DQ26991953-1A10C892-AD34-4460-A200-99B186BC5218Q26999699-6AB60CB7-B01C-46DC-A48A-215494FB8BEAQ27022454-74067FF1-D64C-4BD8-9175-9988D8D298EFQ27026178-CA68A882-C220-456E-8FE3-7046A53834B3Q27346513-60AFDB94-D77B-489D-A52B-08728F1C728DQ28074691-2A09619F-A969-4522-A404-13A89A12CBCFQ28077344-E08FB229-9FEB-48F1-9B85-0AA7B422CE1AQ28391355-92F7F3DB-0CA8-4B78-8394-F2100709D2A1Q28484655-4DCBC6B2-5D8F-4A51-A65B-B870B6A9ABF1Q28507071-68BC7218-02A4-4C87-B1AC-18E2729D73B2Q28540108-F39F3E5A-D991-4D79-9691-34E99783AFBDQ28543724-06EDB172-3A6B-4826-93F3-B55749B334FBQ30415659-DA4A1C32-EED2-414A-8818-C0F55F80ACC8Q31162700-9D190388-07B2-40D2-9041-BA7009DA17E5Q33570512-7CA72D42-78C7-449C-8972-583F998581EAQ33591405-6B35E92A-CB68-4F29-AD45-08653995E514Q33610394-BCB2F957-A020-4EC5-8B97-A5FF3B458CF3Q33649748-5C83F84A-196F-4060-A927-35774E379EECQ33674090-F3036186-A3F7-4F9C-B130-6E44A2C24D20Q33695197-E1A50338-F514-4487-B3DD-96503DEA073DQ33716048-D88BD0DD-FECF-48EF-9F99-23CC2AE86295Q33720431-3DD77E79-F64A-42A5-BE51-297E098BB85EQ33725229-D828B5F6-C982-4CA8-BE23-B272E631AF6EQ33843578-D7BE65D4-C4A9-49A2-9315-99C26458ED5EQ33854787-008236C3-12A0-4ADB-9BED-F067C26518EFQ33863850-C106C5E7-8142-4786-9B0D-6FDBC4FBB91BQ33875560-F39A4FFE-058C-42C0-98D4-4FCBD648A986Q33875694-E49BBA86-CB37-4D74-BBC4-C707B1728904Q33906083-B0BC4098-B97E-438F-A006-1BE167F54139Q33906160-62AFAD77-4790-4541-BC1C-7BA6212BBD3AQ33920975-C7D267D0-C635-42D2-9083-678AAB0742FCQ33924908-3319D1E9-511D-48FC-BF74-69D8FA1E5394Q33986942-05871ECA-CD46-4AEA-9A08-D4FD2B26CDB9
P2860
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Impact of epidermal growth fac ...... anced head and neck carcinoma.
@en
Impact of epidermal growth fac ...... anced head and neck carcinoma.
@nl
type
label
Impact of epidermal growth fac ...... anced head and neck carcinoma.
@en
Impact of epidermal growth fac ...... anced head and neck carcinoma.
@nl
prefLabel
Impact of epidermal growth fac ...... anced head and neck carcinoma.
@en
Impact of epidermal growth fac ...... anced head and neck carcinoma.
@nl
P2093
P1433
P1476
Impact of epidermal growth fac ...... vanced head and neck carcinoma
@en
P2093
Brian A Berkey
Elizabeth H Hammond
Hua-Zhong Zhang
K Kian Ang
Karen K Fu
Luka Milas
P304
P407
P577
2002-12-01T00:00:00Z